The influence of bromocryptine treatment on activity of the adenylyl cyclase system in the brain of rats with type 2 diabetes mellitus induced by high-fat diet

Dokl Biochem Biophys. 2014:459:186-9. doi: 10.1134/S1607672914060027. Epub 2015 Jan 6.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenylyl Cyclases / metabolism*
  • Animals
  • Blood Glucose / drug effects
  • Body Weight / drug effects
  • Brain / drug effects*
  • Brain / enzymology
  • Bromocriptine / pharmacokinetics
  • Bromocriptine / pharmacology*
  • Diabetes Mellitus, Experimental / drug therapy*
  • Diabetes Mellitus, Experimental / enzymology
  • Diabetes Mellitus, Type 2
  • Diet, High-Fat
  • Dopamine / metabolism
  • Hypoglycemic Agents / pharmacokinetics
  • Hypoglycemic Agents / pharmacology*
  • Male
  • Norepinephrine / metabolism
  • Rats, Wistar
  • Receptors, Dopamine D2 / agonists
  • Receptors, Dopamine D2 / metabolism
  • Relaxin / metabolism
  • Serotonin / metabolism
  • Somatostatin / metabolism

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Receptors, Dopamine D2
  • Serotonin
  • Bromocriptine
  • Somatostatin
  • Relaxin
  • Adenylyl Cyclases
  • Dopamine
  • Norepinephrine